insights_auto
Why is ORMP down 2.64%?
Dive Deeperchevron_right
ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$4.43
arrow_downward
-2.64%(-0.12) 1D
Oct 6, 1:21:32 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.55
High
$4.58
Low
$4.43
Mkt. cap
181.85M
Avg. vol.
210.54K
Volume
35.56K
P/E ratio
1.07
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
Open
$4.55
High
$4.58
Low
$4.43
Mkt. cap
181.85M
Avg. vol.
210.54K
Volume
35.56K
P/E ratio
1.07
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
MarketForces Africa
·
44 minutes ago
XRP Establishes Price Floor Ahead Of Evernorth Nasdaq Listing
Simply Wall Street
·
18 minutes ago
Sovereign AI Deal Might Change The Case For Investing In Palantir (PLTR)
CNBC
·
15 minutes ago
How the S&P 500 can be at record highs, while the market remains oversold
NBC News
·
3 hours ago
S&P 500 hits record high as Nvidia nears $6 trillion milestone
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.